VRS
ACAD icon

Virginia Retirement Systems’s Acadia Pharmaceuticals ACAD Stock Holding History

Virginia Retirement Systems’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Buy
83,398
+2,400
+3% +$52.8K 0.01% 522
2026
Q1 		$1.8M Buy
80,998
+1,100
+1% +$26.3K 0.01% 455
2025
Q4 		$2.13M Buy
79,898
+18,050
+29% +$431K 0.01% 404
2025
Q3 		$1.32M Sell
61,848
-900
-1% -$21.3K 0.01% 515
2025
Q2 		$1.35M Sell
62,748
-8,700
-12% -$162K 0.01% 503
2025
Q1 		$1.19M Buy
+71,448
New +$1.3M 0.01% 521
2023
Q3 		$882K Sell
42,300
-15,100
-26% -$410K 0.01% 544
2023
Q2 		$1.37M Buy
57,400
+19,700
+52% +$438K 0.01% 457
2023
Q1 		$710K Buy
37,700
+8,300
+28% +$158K 0.01% 640
2022
Q4 		$468K Sell
29,400
-4,300
-13% -$67.2K ﹤0.01% 845
2022
Q3 		$551K Buy
+33,700
New +$546K 0.01% 781
2022
Q1 		$862K Sell
35,600
-2,000
-5% -$48.4K 0.01% 693
2021
Q4 		$878K Buy
37,600
+200
+0.5% +$4.02K 0.01% 703
2021
Q3 		$621K Buy
37,400
+6,700
+22% +$129K 0.01% 754
2021
Q2 		$749K Buy
30,700
+16,400
+115% +$370K 0.01% 740
2021
Q1 		$369K Buy
14,300
+1,700
+13% +$74.8K ﹤0.01% 951
2020
Q4 		$674K Sell
12,600
-15,100
-55% -$750K 0.01% 743
2020
Q3 		$1.14M Sell
27,700
-3,000
-10% -$130K 0.01% 511
2020
Q2 		$1.49M Buy
30,700
+3,300
+12% +$158K 0.02% 457
2020
Q1 		$1.16M Buy
27,400
+20,900
+322% +$861K 0.02% 495
2019
Q4 		$278K Buy
+6,500
New +$283K ﹤0.01% 1050

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Virginia Retirement Systems's ACAD Position: Q2 2026 in Review

Virginia Retirement Systems increased its Acadia Pharmaceuticals (ACAD) stake by 3% in Q2 2026, buying an estimated $52.8K and bringing the position to 83,398 shares worth $2.11M. The position accounts for 0.01% of the portfolio, ranked #522.

Virginia Retirement Systems first reported a position in ACAD in Q4 2019 and has held it in 21 quarters since. The position peaked at $2.13M in Q4 2025. 353 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Virginia Retirement Systems held 83,398 shares of Acadia Pharmaceuticals worth $2.11M as of Q2 2026.
  • Virginia Retirement Systems bought 2,400 Acadia Pharmaceuticals shares in Q2 2026, an estimated $52.8K.
  • Acadia Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #522 holding.
  • Virginia Retirement Systems first reported a position in Acadia Pharmaceuticals in Q4 2019 and has held it in 21 quarters since.
  • Virginia Retirement Systems's Acadia Pharmaceuticals position peaked at $2.13M in Q4 2025.
  • 353 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.